Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection
Status:
Completed
Trial end date:
2021-03-18
Target enrollment:
Participant gender:
Summary
To compare the efficacy of Helicobacter pylori (HP) eradication with vonoprazan dual and
triple therapy regimens versus lansoprazole triple therapy regimen in participants with HP
infection, excluding participants who had a clarithromycin or amoxicillin resistant strain of
HP at baseline.